Publications and communications of Michelle PIROTTE

Pirotte, M. (2024). Detailed investigation of erythropoiesis and iron metabolism in the context of allogeneic hematopoietic stem cell transplantation [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314588

Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837
* These authors have contributed equally to this work.

De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266

Rizzo, O., PIROTTE, M., Roussel, M., & Jaccard, A. (31 December 2021). Amylose AL. Correspondances en Onco-Hématologie, XVI-N°6 (novembre-décembre), 298-302.

PIROTTE, M., Fillet, M., SEIDEL, L., JASPERS, A., Baron, F., & Beguin, Y. (2021). Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. American Journal of Hematology, 96 (10), 1275-1286. doi:10.1002/ajh.26300

Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488.

SIBILLE, A., Alfieri, R., MALAISE, O., DETREMBLEUR, N., Pirotte, M., Louis, R., & DUYSINX, B. (06 June 2019). Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer. Frontiers in Oncology, 9, 478. doi:10.3389/fonc.2019.00478

Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003
* These authors have contributed equally to this work.

PIROTTE, M., Delens, A., Wahlen, C., DOME, F., Couvreur, T., Guillevin, L., & Ramaut, M. (2016). Ce n'était pas une myasthénie. Vaisseaux, Coeur, Poumons, 21, N°5.

Pirotte, M., GUIOT, J., BEGUIN, Y., & Louis, R. (2016). L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit. Revue Médicale de Liège, 71 (11), 488-494.